CLK-IN-T3
CAS: 2109805-56-1
Ref. 3D-JJD80556
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Información del producto
CLK-IN-T3 is a small molecule that has been shown to induce apoptosis in cancer cells. CLK-IN-T3 induces the activation of caspase 3, which is involved in the execution phase of apoptosis. CLK-IN-T3 also synergizes with other chemotherapeutic agents, such as doxorubicin and vincristine, to induce cell death. CLK-IN-T3 has been shown to inhibit neurodevelopmental processes and enhances apoptotic signaling pathways in hCT116 colon cancer cells. This drug may be useful for combination strategies for cancer therapy.
Propiedades químicas
Consulta técnica sobre: 3D-JJD80556 CLK-IN-T3
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
